Jin Gohda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jin Gohda has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Jun-Ichiro Inoue
Research Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
2 shared publications Danyang Xu
Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, Canada
1 shared publication- David Lorne Tyrrell
University of Alberta
1 shared publication Eiji Goto
Department of Pathobiochemistry, Graduate School of Medicine, Osaka City University, Osaka, Japan
1 shared publicationEstefany Y. Reyes
Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA 91010
1 shared publication- Fuminori Tokunaga
Department of Medical Biochemistry, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan
1 shared publication
Latest Publications
- Open Access
- 1 May 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 930086
Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection
Interferon regulatory factors (IRFs) are key elements of antiviral innate responses that regulate the transcription of interferons (IFNs) and IFN-stimulated genes (ISGs). While the sensitivity of human coronaviruses to IFNs has been characterized, antiviral roles of IRFs during human coronavirus infection are not fully understood. Type I or II IFN treatment protected MRC5 cells from human coronavirus 229E infection, but not OC43. Cells infected with 229E or OC43 upregulated ISGs, indicating that antiviral transcription is not suppressed. Antiviral IRFs, IRF1, IRF3 and IRF7, were activated in cells infected with 229E, OC43 or severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2). RNAi knockdown and overexpression of IRFs demonstrated that IRF1 and IRF3 have antiviral properties against OC43, while IRF3 and IRF7 are effective in restricting 229E infection. IRF3 activation effectively promotes transcription of antiviral genes during OC43 or 229E infection. Our study suggests that IRFs may be effective antiviral regulators against human coronavirus infection.
- 1 May 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 930086
Open AccessInterferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection
Interferon regulatory factors (IRFs) are key elements of antiviral innate responses that regulate the transcription of interferons (IFNs) and IFN-stimulated genes (ISGs). While the sensitivity of human coronaviruses to IFNs has been characterized, antiviral roles of IRFs during human coronavirus infection are not fully understood. Type I or II IFN treatment protected MRC5 cells from human coronavirus 229E infection, but not OC43. Cells infected with 229E or OC43 upregulated ISGs, indicating that antiviral transcription is not suppressed. Antiviral IRFs, IRF1, IRF3 and IRF7, were activated in cells infected with 229E, OC43 or severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2). RNAi knockdown and overexpression of IRFs demonstrated that IRF1 and IRF3 have antiviral properties against OC43, while IRF3 and IRF7 are effective in restricting 229E infection. IRF3 activation effectively promotes transcription of antiviral genes during OC43 or 229E infection. Our study suggests that IRFs may be effective antiviral regulators against human coronavirus infection.
- Open Access
- 7 August 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (34) , E7140-E7149
miR-146a – Traf6 regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression
Significance: Aberrant inflammation is the root cause of numerous human diseases, from autoimmunity to cancer. microRNA-146a ( miR-146a ), a member of a large class of small regulatory RNAs, functions as a critical molecular brake on inflammation and malignant transformation. However, the molecular mechanism through which miR-146a exerts its regulatory activity in immune cells is unclear. Using mouse genetics, we have examined the role of the miR-146a–Traf6 signaling axis and found that although this miRNA–target interaction is responsible for regulating normal myeloid cell development and autoimmunity, it is dispensable for hematopoietic stem cell homeostasis and tumor suppression.
- 7 August 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (34) , E7140-E7149
Open AccessmiR-146a – Traf6 regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression
Significance: Aberrant inflammation is the root cause of numerous human diseases, from autoimmunity to cancer. microRNA-146a ( miR-146a ), a member of a large class of small regulatory RNAs, functions as a critical molecular brake on inflammation and malignant transformation. However, the molecular mechanism through which miR-146a exerts its regulatory activity in immune cells is unclear. Using mouse genetics, we have examined the role of the miR-146a–Traf6 signaling axis and found that although this miRNA–target interaction is responsible for regulating normal myeloid cell development and autoimmunity, it is dispensable for hematopoietic stem cell homeostasis and tumor suppression.
- Open Access
- 21 April 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1009
Basal autophagy prevents autoactivation or enhancement of inflammatory signals by targeting monomeric MyD88
Autophagy, the processes of delivery of intracellular components to lysosomes, regulates induction of inflammation. Inducible macroautophagy degrades inflammasomes and dysfunctional mitochondria to downregulate inflammatory signals. Nonetheless, the effects of constitutive basal autophagy on inflammatory signals are largely unknown. Here, we report a previously unknown effect of basal autophagy. Lysosomal inhibition induced weak inflammatory signals in the absence of a cellular stimulus and in the presence of a nutrient supply, and their induction was impaired by MyD88 deficiency. During lysosomal inhibition, MyD88 was accumulated, and overabundant MyD88 autoactivated downstream signaling or enhanced TLR/IL-1R-mediated signaling. MyD88 is probably degraded via basal microautophagy because macroautophagy inhibitors, ATG5 deficiency, and an activator of chaperone-mediated autophagy did not affect MyD88. Analysis using a chimeric protein whose monomerization/dimerization can be switched revealed that monomeric MyD88 is susceptible to degradation. Immunoprecipitation of monomeric MyD88 revealed its interaction with TRAF6. In TRAF6-deficient cells, degradation of basal MyD88 was enhanced, suggesting that TRAF6 participates in protection from basal autophagy. Thus, basal autophagy lowers monomeric MyD88 expression, and thereby autoactivation of inflammatory signals is prevented. Given that impairment of lysosomes occurs in various settings, our results provide novel insights into the etiology of inflammatory signals that affect consequences of inflammation.
- 21 April 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1009
Open AccessBasal autophagy prevents autoactivation or enhancement of inflammatory signals by targeting monomeric MyD88
Autophagy, the processes of delivery of intracellular components to lysosomes, regulates induction of inflammation. Inducible macroautophagy degrades inflammasomes and dysfunctional mitochondria to downregulate inflammatory signals. Nonetheless, the effects of constitutive basal autophagy on inflammatory signals are largely unknown. Here, we report a previously unknown effect of basal autophagy. Lysosomal inhibition induced weak inflammatory signals in the absence of a cellular stimulus and in the presence of a nutrient supply, and their induction was impaired by MyD88 deficiency. During lysosomal inhibition, MyD88 was accumulated, and overabundant MyD88 autoactivated downstream signaling or enhanced TLR/IL-1R-mediated signaling. MyD88 is probably degraded via basal microautophagy because macroautophagy inhibitors, ATG5 deficiency, and an activator of chaperone-mediated autophagy did not affect MyD88. Analysis using a chimeric protein whose monomerization/dimerization can be switched revealed that monomeric MyD88 is susceptible to degradation. Immunoprecipitation of monomeric MyD88 revealed its interaction with TRAF6. In TRAF6-deficient cells, degradation of basal MyD88 was enhanced, suggesting that TRAF6 participates in protection from basal autophagy. Thus, basal autophagy lowers monomeric MyD88 expression, and thereby autoactivation of inflammatory signals is prevented. Given that impairment of lysosomes occurs in various settings, our results provide novel insights into the etiology of inflammatory signals that affect consequences of inflammation.
- Open Access
- 19 January 2017
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 13 (1) , e1006162
HTLV-1 Tax Induces Formation of the Active Macromolecular IKK Complex by Generating Lys63- and Met1-Linked Hybrid Polyubiquitin Chains
The Tax protein of human T-cell leukemia virus type 1 (HTLV-1) is crucial for the development of adult T-cell leukemia (ATL), a highly malignant CD4+ T cell neoplasm. Among the multiple aberrant Tax-induced effects on cellular processes, persistent activation of transcription factor NF-κB, which is activated only transiently upon physiological stimulation, is essential for leukemogenesis. We and others have shown that Tax induces activation of the IκB kinase (IKK) complex, which is a critical step in NF-κB activation, by generating Lys63-linked polyubiquitin chains. However, the molecular mechanism underlying Tax-induced IKK activation is controversial and not fully understood. Here, we demonstrate that Tax recruits linear (Met1-linked) ubiquitin chain assembly complex (LUBAC) to the IKK complex and that Tax fails to induce IKK activation in cells that lack LUBAC activity. Mass spectrometric analyses revealed that both Lys63-linked and Met1-linked polyubiquitin chains are associated with the IKK complex. Furthermore, treatment of the IKK-associated polyubiquitin chains with Met1-linked-chain-specific deubiquitinase (OTULIN) resulted in the reduction of high molecular weight polyubiquitin chains and the generation of short Lys63-linked ubiquitin chains, indicating that Tax can induce the generation of Lys63- and Met1-linked hybrid polyubiquitin chains. We also demonstrate that Tax induces formation of the active macromolecular IKK complex and that the blocking of Tax-induced polyubiquitin chain synthesis inhibited formation of the macromolecular complex. Taken together, these results lead us to propose a novel model in which the hybrid-chain-dependent oligomerization of the IKK complex triggered by Tax leads to trans-autophosphorylation-mediated IKK activation. NF-κB is a key transcription factor that regulates many physiologically important cellular processes. However, persistent activation of NF-κB leads to chronic inflammation, autoimmunity and malignancy. Infection with the human retrovirus HTLV-1 causes adult T-cell leukemia, and HTLV-1 Tax-mediated persistent NF-κB activation is crucial for leukemogenesis. Therefore, a better understanding of the precise mechanism underlying aberrant NF-κB activation is essential to develop new therapeutic approaches. Ubiquitination is one of the major post-translational modifications that regulate various intracellular signaling pathways. We and others have shown that Tax activates NF-κB through activation of the IκB kinase (IKK) complex by generating Lys63-linked polyubiquitin chains. However, the molecular mechanism underlying Tax-induced IKK activation remains less well understood. Here, we demonstrate precisely how HTLV-1 Tax utilizes the ubiquitin system to activate the IKK complex. The IKK complex-associated Lys63/Met1-linked hybrid polyubiquitin chains are generated through the Tax-mediated recruitment of linear ubiquitin chain assembly complex (LUBAC) to the IKK complex. Furthermore, the hybrid chains are required for the Tax-induced formation of the active macromolecular IKK complex. Accordingly, we propose a novel model in which Tax triggers Lys63/Met1-linked hybrid-chain-dependent oligomerization of the IKK complex, leading to trans-autophosphorylation-mediated IKK activation.
- 19 January 2017
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 13 (1) , e1006162
Open AccessHTLV-1 Tax Induces Formation of the Active Macromolecular IKK Complex by Generating Lys63- and Met1-Linked Hybrid Polyubiquitin Chains
The Tax protein of human T-cell leukemia virus type 1 (HTLV-1) is crucial for the development of adult T-cell leukemia (ATL), a highly malignant CD4+ T cell neoplasm. Among the multiple aberrant Tax-induced effects on cellular processes, persistent activation of transcription factor NF-κB, which is activated only transiently upon physiological stimulation, is essential for leukemogenesis. We and others have shown that Tax induces activation of the IκB kinase (IKK) complex, which is a critical step in NF-κB activation, by generating Lys63-linked polyubiquitin chains. However, the molecular mechanism underlying Tax-induced IKK activation is controversial and not fully understood. Here, we demonstrate that Tax recruits linear (Met1-linked) ubiquitin chain assembly complex (LUBAC) to the IKK complex and that Tax fails to induce IKK activation in cells that lack LUBAC activity. Mass spectrometric analyses revealed that both Lys63-linked and Met1-linked polyubiquitin chains are associated with the IKK complex. Furthermore, treatment of the IKK-associated polyubiquitin chains with Met1-linked-chain-specific deubiquitinase (OTULIN) resulted in the reduction of high molecular weight polyubiquitin chains and the generation of short Lys63-linked ubiquitin chains, indicating that Tax can induce the generation of Lys63- and Met1-linked hybrid polyubiquitin chains. We also demonstrate that Tax induces formation of the active macromolecular IKK complex and that the blocking of Tax-induced polyubiquitin chain synthesis inhibited formation of the macromolecular complex. Taken together, these results lead us to propose a novel model in which the hybrid-chain-dependent oligomerization of the IKK complex triggered by Tax leads to trans-autophosphorylation-mediated IKK activation. NF-κB is a key transcription factor that regulates many physiologically important cellular processes. However, persistent activation of NF-κB leads to chronic inflammation, autoimmunity and malignancy. Infection with the human retrovirus HTLV-1 causes adult T-cell leukemia, and HTLV-1 Tax-mediated persistent NF-κB activation is crucial for leukemogenesis. Therefore, a better understanding of the precise mechanism underlying aberrant NF-κB activation is essential to develop new therapeutic approaches. Ubiquitination is one of the major post-translational modifications that regulate various intracellular signaling pathways. We and others have shown that Tax activates NF-κB through activation of the IκB kinase (IKK) complex by generating Lys63-linked polyubiquitin chains. However, the molecular mechanism underlying Tax-induced IKK activation remains less well understood. Here, we demonstrate precisely how HTLV-1 Tax utilizes the ubiquitin system to activate the IKK complex. The IKK complex-associated Lys63/Met1-linked hybrid polyubiquitin chains are generated through the Tax-mediated recruitment of linear ubiquitin chain assembly complex (LUBAC) to the IKK complex. Furthermore, the hybrid chains are required for the Tax-induced formation of the active macromolecular IKK complex. Accordingly, we propose a novel model in which Tax triggers Lys63/Met1-linked hybrid-chain-dependent oligomerization of the IKK complex, leading to trans-autophosphorylation-mediated IKK activation.